Showing results (291-300 of 334) with videos related to
Sort By:
Pageof 34
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 23, 2017
Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-AnalysisSuzanne Nielsen, Pamela Sabioni, Jose M Trigo, et al.Eclinicalmedicine|December 9, 2020
Risk factors for indicators of opioid-related harms amongst people living with chronic non-cancer pain: Findings from a 5-year prospective cohort studyGabrielle Campbell, Firouzeh Noghrehchi, Suzanne Nielsen, et al.Drug and Alcohol Review|July 23, 2026
Patient Experience of Withdrawal During Methadone-Buprenorphine Transfer: A Prospective Cohort StudyChris Tremonti, Llewellyn Mills, Nicholas Lintzeris, et al.Drug and Alcohol Review|September 14, 2021
Opioid agonist treatment and patient outcomes during the COVID-19 pandemic in south east Sydney, AustraliaNicholas Lintzeris, Rachel M Deacon, Victoria Hayes, et al.Journal of Addiction Medicine|November 20, 2019
Consensus and Controversies Between Pain and Addiction Experts on the Prevention, Diagnosis, and Management of Prescription Opioid Use DisorderMark Kraus, Nicholas Lintzeris, Arun Bhaskar, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 23, 2022
Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studiesSuzanne Nielsen, Louisa Picco, Bridin Murnion, et al.Drug and Alcohol Review|February 19, 2026
Experiences of People Who Discontinue Long-Acting Injectable Buprenorphine Treatment Recently Released From Prison in New South Wales, AustraliaLucy J D Peck, Bethany White, Maja Moensted, et al.Addiction (Abingdon, England)|April 24, 2019
Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorderMichael Frost, Genie L Bailey, Nicholas Lintzeris, et al.Drug and Alcohol Dependence|April 4, 2017
Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trialAdrian J Dunlop, Amanda L Brown, Christopher Oldmeadow, et al.The International Journal on Drug Policy|January 13, 2017
Following Lives Undergoing Change (Flux) study: Implementation and baseline prevalence of drug use in an online cohort study of gay and bisexual men in AustraliaMohamed A Hammoud, Fengyi Jin, Louisa Degenhardt, et al.Pageof 34